BLNK vs IBRX · rev $42.5M vs rev $51.2M
Blink Charging Co (BLNK) versus Immunitybio Inc (IBRX) — a side-by-side from cached financials, not a winner call.
Blink Charging Co (BLNK) is a engineering & construction company listed on NASDAQ.
Immunitybio Inc (IBRX) is a biotechnology company listed on US.
Latest reported BLNK revenue for 2026-06-30 was $42.5M. Net income was -$17.6M. BLNK currently screens at market cap $94.0M.
Latest reported IBRX revenue for 2026-06-30 was $51.2M. Net income was -$230.4M. Revenue was up 15.9% from 2026-03-31 to 2026-06-30. IBRX currently screens at market cap $7.88B.
BLNK currently screens at market cap $94.0M. IBRX currently screens at market cap $7.88B.
Not investment advice. Open the BLNK and IBRX stock pages for the full models.
Not investment advice.